Why Banks Won't Lend to Cannabis Businesses, and Who Will

By MercFinancial · Published 2026-10-21

Banks will not lend to cannabis businesses because cannabis is a Schedule I substance under federal law, which turns every loan into a Bank Secrecy Act exposure. Private and asset-based lenders fund around it.

Banks will not lend to cannabis businesses because cannabis is a Schedule I controlled substance under the federal Controlled Substances Act, and a federally chartered or federally insured bank cannot treat the proceeds of a federally illegal business as ordinary loan collateral. The refusal is not a view on your credit. It is a judgment about the bank's own exposure under federal criminal law, the Bank Secrecy Act and its regulators, and the SBA's eligibility rule closes the government-backed route as well. Who does lend is a different set of funding sources that price the federal risk instead of avoiding it.

This guide explains each layer of the decline: the Controlled Substances Act, the anti-money-laundering burden a single cannabis account creates, the SBA exclusion and the policy notice that widened it, and what the SAFE Banking Act of 2026 and federal rescheduling would and would not change. It then names the lender types that fund cannabis today and what they look for.

The bank is not declining your dispensary. It is declining a federal exposure its charter cannot carry, so the yes comes from private capital.

Federal law makes a cannabis loan a federal problem for the bank

A bank is a federal creature even when its charter is from a state. Its deposits are federally insured, its examiners answer to federal agencies, and its access to the payment system runs through the Federal Reserve. Cannabis sits on Schedule I of the Controlled Substances Act, and that status does not change because a state has licensed the grower or the store. Revenue from a licensed dispensary is, in federal terms, the proceeds of an unlawful activity.

A loan secured by that revenue, or repaid from it, puts the bank in a transaction with those proceeds. Bank counsel reads that against the federal money-laundering statutes and the bank's own regulatory standing, and the conclusion is nearly always that the credit income is not worth the institutional risk. That is why the decline arrives before anyone has looked at your financials. The answer is policy, written at the top of the bank, and no loan officer can override it.

BSA and AML: what one cannabis account costs a bank

The Bank Secrecy Act requires a bank to know its customer, monitor activity and file suspicious activity reports. FinCEN guidance issued in 2014 describes how a bank may serve a marijuana-related business at all: enhanced due diligence on the license and the owners, continuous monitoring against state law, and a suspicious activity report on the relationship that is refiled on a schedule for as long as the account stays open. The guidance created a path, and it also made clear how expensive the path is.

That expense is why the institutions that do serve cannabis are mostly smaller state-chartered banks and credit unions charging a monthly compliance fee for a deposit account. Deposits are a contained exposure. A loan adds credit risk, collateral the bank may not be able to liquidate, and a multi-year relationship with a borrower whose legal status could shift. Most cannabis-friendly depositories therefore lend rarely, and when they do it is usually against real estate in a mature state market.

The SBA exclusion and the policy notice that widened it

The SBA's rule is 13 CFR 120.110(h): a business engaged in any activity that is illegal under federal, state or local law is ineligible. That alone closes the 7(a) and 504 programs to any plant-touching business. In 2018 the SBA went further with Policy Notice 5000-17057, which defined a direct marijuana business as one that grows, produces, processes, distributes or sells marijuana or marijuana products, and an indirect marijuana business as one that earns revenue from selling products or services to direct businesses, naming testing labs and sellers of grow lights and hydroponic equipment as examples.

The practical effect is that an SBA lender will ask an ancillary business what share of its revenue comes from licensees, and a meaningful answer ends the conversation. Hemp is the exception. A later revision of the SBA's standard operating procedure made businesses working with hemp, as defined after the 2018 Farm Bill, eligible, which is the opening described in CBD and hemp business loans.

SAFE Banking, rescheduling and what they would not change

Two federal developments come up in every cannabis financing conversation. The SAFE Banking Act of 2026 was reintroduced in the Senate and the House in June 2026. It would give banks and credit unions a safe harbor for serving state-legal cannabis businesses, and it contemplates loans and card processing, not only deposits. As of this writing it has not become law, and earlier versions passed the House repeatedly without clearing the Senate.

On scheduling, a DEA order in April 2026 moved FDA-approved marijuana drug products and marijuana held under qualifying state medical licenses to Schedule III, while a broader rescheduling proposal remains in an administrative hearing process. Adult-use cannabis remains Schedule I. Federally insured banks and the SBA have not, as of this writing, changed their treatment of plant-touching businesses because of that order. Even a full safe harbor would make lending permitted, not required. Credit policy would still be each bank's decision, and the early loans would likely go to operators with real estate, operating history and clean compliance records.

Who will lend to a cannabis business, and why they can

The funding sources that write cannabis today share one trait: they are not federally insured depositories, so the Bank Secrecy Act exposure that stops a bank is either absent or already priced into their model.

The full menu, with what each structure funds and costs, is in cannabis business loans: what financing exists. The general playbook for turning a bank decline into a placement elsewhere is in the bank declined business loan playbook, and most of it applies, with the difference that in cannabis the bank was never the first stop.

Mistakes that turn a cannabis policy decline into a credit decline

A bank decline costs nothing but time. A decline from a cannabis lender goes on the record of a small market where underwriters talk. These are the avoidable ones.

• Applying at a national bank or a large online lender anyway, taking the hard inquiry, and then explaining the decline to a specialty lender.
• Running the business through personal accounts because no bank would open a business account, which leaves no clean deposit history to underwrite.
• Filing federal returns that ignore Section 280E, so the lender's own adjustment shows far less cash flow than the owner claimed.
• Pitching the SAFE Banking Act or rescheduling as a reason the loan is safe. Lenders underwrite the law as it stands.
• Leaving undisclosed owners or financiers off the cap table the state approved.

Where MercFinancial fits

MercFinancial is a commercial funding brokerage, not a bank and not a lender, and it does not change the federal picture described here. What it does is skip the declines. A specialist reads the file first, sorts it as plant-touching or ancillary, and identifies, from a network of more than 160 wholesale and institutional funding sources, the ones whose written credit policy allows cannabis and the structure requested. One file goes to all of them, the offers are compared on total cost and terms, and every loan is made by the third-party funding source on its own approval, amount, rate and fees. Availability depends on the funding source, and when no policy fits, the answer is a plain no with the reason. Start with the cannabis business funding hub or a business funding conversation.

Frequently Asked Questions

Why won't my bank give my dispensary a loan when the state licensed it?

Because the bank's exposure is federal, not state. Cannabis is a Schedule I controlled substance under the Controlled Substances Act, so a loan repaid from dispensary revenue is a transaction in federally unlawful proceeds, with Bank Secrecy Act reporting attached. Most banks decline the industry by written policy, and the few that serve it usually limit the relationship to deposit accounts.

Will the SAFE Banking Act let cannabis businesses get bank loans?

Not yet, and not automatically. The SAFE Banking Act of 2026, reintroduced in June 2026, would give banks a safe harbor for serving state-legal cannabis businesses, including loans. As of this writing it has not become law. If it passes, lending becomes permitted rather than required, and each bank's credit policy would still decide whether and whom it funds.

Did the 2026 rescheduling change cannabis banking?

Not for most operators. The April 2026 DEA order moved FDA-approved marijuana drug products and marijuana under qualifying state medical licenses to Schedule III, while adult-use cannabis stayed on Schedule I and a broader proposal remains pending. As of this writing, federally insured banks and the SBA have not changed how they treat plant-touching businesses because of it.

Is an ancillary cannabis business eligible for an SBA loan?

Often not. SBA Policy Notice 5000-17057 defined an indirect marijuana business as one earning revenue from products or services sold to direct marijuana businesses, naming testing labs and grow-light sellers as examples, and treated it as ineligible. An SBA lender will ask what share of revenue comes from licensees. Hemp businesses, by contrast, can be eligible under later SBA guidance.

What does a cannabis lender want to see that a bank never asked about?

The license and inspection record, a 280E-adjusted profit and loss statement, twelve months of statements from a compliant depository account, point-of-sale and state track-and-trace data that reconcile to deposits, a collateral schedule with equipment serial numbers, and the ownership table the state approved. Cannabis lenders underwrite compliance and recoverable assets before they underwrite growth.

MercFinancial is a commercial funding brokerage in Houston, Texas. MercFinancial is a broker, not a lender: every loan is made by a third-party funding source, every request is subject to that source's underwriting and credit approval, and loan amounts, advance rates, interest rates, terms, fees, collateral and guaranty requirements vary by funding source and borrower and are not guaranteed. Nothing here is a commitment to lend or an offer of credit, and financing is for business purposes only. Any example in this guide is hypothetical and illustrative; actual terms and outcomes vary. Cannabis remains a Schedule I controlled substance under federal law; the availability of financing for any cannabis-related business depends on the funding source's own policies and on state and federal law, and nothing here is legal advice. This guide is educational only and is not legal, tax, accounting or investment advice.